Search Results - "Lucci, J A"

Ureteroarterial fistula by McCullough, M. C., Oh, E. E., Lucci, J. A., Alvarez, E. A.

“…The authors intended to perform a comprehensive review of the literature pertaining to ureteroarterial fistulae and apply the findings to a case. A…”
Get full text

Purification and Characterization of an Inhibitor (Soluble Tumor Necrosis Factor Receptor) for Tumor Necrosis Factor and Lymphotoxin Obtained from the Serum Ultrafiltrates of Human Cancer Patients by Gatanaga, Tetsuya, Hwang, Chenduen, Kohr, William, Cappuccini, Fabio, Lucci, Joseph A., Edward W. B. Jeffes, Lentz, Rigdon, Tomich, John, Yamamoto, Robert S., Granger, Gale A.

“…Serum ultrafiltrates (SUF) from human patients with different types of cancer contain a blocking factor (BF) that inhibits the cytolytic activity of human…”
Get full text

Adenovirus-Based p53 Gene Therapy in Ovarian Cancer by SANTOSO, JOSEPH T., TANG, DE-CHU, LANE, STEVEN B., HUNG, JACLYN, REED, DEBORAH J., MULLER, CAROLYN Y., CARBONE, DAVID P., LUCCIIII, JOSEPH A., SCOTTMILLER, DAVID, MATHIS, MICHAEL J.

“…Mutations of the p53 tumor suppressor gene are the most common molecular genetic abnormality to be described in ovarian cancer. To determine the feasibility of…”
Get full text

Growth hormone-releasing hormone antagonists inhibit growth of human ovarian cancer by Papadia, A, Schally, A V, Halmos, G, Varga, J L, Seitz, S, Buchholz, S, Rick, F, Zarandi, M, Bellyei, S, Treszl, A, Szalontay, L, Lucci, J A

“…Epithelial ovarian carcinoma is the leading cause of cancer-related deaths among women with gynecologic malignancies. Antagonists of the growth…”
Get more information

Primary vaginal melanoma: improved survival with radical pelvic surgery by Van Nostrand, K M, Lucci, 3rd, J A, Schell, M, Berman, M L, Manetta, A, DiSaia, P J

“…Primary vaginal melanoma is an aggressive and rare gynecological malignancy with < 150 reported cases to date. Historically, patients with this disease have a…”
Get more information

Prognostic nutritional index in relation to hospital stay in women with gynecologic cancer by Santoso, Joseph T, Canada, Todd, Latson, Bernadette, Aaaadi, Kalyani, Lucci, Joseph A, Coleman, Robert L

“…Objective: To estimate the prevalence of malnutrition, correlate it with length of hospital stay, and evaluate laboratory tools to define it in gynecologic…”
Get full text

A Phase II Trial of Neoadjuvant Chemotherapy Prior to Radical Hysterectomy and/or Radiation Therapy in the Management of Advanced Carcinoma of the Uterine Cervix by Bloss, Jeffrey D., Lucci, Joseph A., DiSaia, Philip J., Manetta, Alberto, Schiano, Michael A., Ramsinghani, Nilam, Berman, Michael L.

“…Objective: This prospective trial was designed to access the efficacy and safety of neoadjuvant chemotherapy followed by radical hysterectomy and/or radiation…”
Get full text

To drain or not to drain: a retrospective study of closed-suction drainage following radical hysterectomy with pelvic lymphadenectomy by Jensen, J K, Lucci, 3rd, J A, DiSaia, P J, Manetta, A, Berman, M L

“…The records of 115 patients were reviewed following radical hysterectomy with pelvic lymphadenectomy for early stage (IA2 to IIB) cervical cancer to determine…”
Get more information

Does Glutamine Supplementation Increase Radioresistance in Squamous Cell Carcinoma of the Cervix? by Santoso, Joseph T., Lucci, Joseph A., Coleman, Robert L., Hatch, Sandra, Wong, Ping, Miller, David, Mathis, J.Michael

“…Objective.Glutamine is proposed to protect bowel from radiation. However, glutamine may decrease cancer's radiosensitivity. We evaluate glutamine's effect on…”
Get full text

Oncogene expression and microvessel count in recurrent and nonrecurrent stage Ib squamous cell carcinoma of the cervix by HOVE, M. G. M, DINH, T. V, HANNIGAN, E. V, LUCCI, J. A, CHOPRA, V, SMITH, E. R, TO, T

“…To evaluate p53, epidermal growth factor receptor (EGFR) and c-erbB-2 oncogene expression and compare it with microvessel count (MVC) in determining the…”
Get full text

Benign adrenal cyst presenting in a pregnant patient by Tait, D L, Williams, J, Sandstad, J, Lucci, 3rd, J A

“…Cystic lesions of the adrenal gland are uncommon, most often diagnosed incidentally during diagnostic imaging or autopsy. An adrenal cyst presenting as a…”
Get more information

Phase I studies of continuous-infusion paclitaxel given with standard aggressive radiation therapy for locally advanced solid tumors by Rosenthal, D I, Close, L G, Lucci, 3rd, J A, Schold, S C, Truelson, J, Fathallah-Skaykh, H, Kamen, B, Vuitch, F M, Gazdar, A F, Griener, J

“…Currently available therapies are unsatisfactory for locally advanced solid tumors of the lung, head and neck, and brain. Laboratory data suggest that the…”
Get more information

Primary lung choriocarcinoma masquerading as a metastatic gestational neoplasm by Van Nostrand, K M, Lucci, 3rd, J A, Liao, S Y, Di Saia, P J

“…Primary lung choriocarcinoma has rarely been reported. In females, previous pregnancies and other sources of trophoblastic tissue such as a nongestational…”
Get more information

The Effect of Naproxen on Fever in Patients with Advanced Gynecologic Malignancies by Economos, Katherine, Lucci, Joseph A., Richardson, Barbara, Yazigi, Roberto, Miller, David Scott

“…The antipyretic action of naproxen has been reported as sufficiently selective for neoplasm-related fever such that the use of this agent has been recommended…”
Get full text

A Phase II trial of amonafide in patients with nonsquamous cell carcinoma of the cervix : A Gynecologic Oncology Group study by ASBURY, R, BLESSING, J. A, LOOK, K. Y, BULLER, R, LUCCI, J. A

“…Twenty-seven patients with nonsquamous cell carcinoma of the cervix were entered into a Phase II study of amonatide; 24 patients were evaluable for toxicity,…”
Get full text

Trafficking of syngeneic murine lymphokine activated killer T cells following intraperitoneal administration in normal and tumor bearing mice by Cappuccini, F, Lucci, 3rd, J A, Dett, C A, Gatanaga, M, Ininns, E K, Gatanaga, T, Yamamoto, R S, Manetta, A, DiSaia, P J, Granger, G A

“…Nongenetically restricted T cells may be important host effector cells in women with ovarian cancer receiving intraperitoneal (ip) IL-2 therapy. We developed…”
Get more information

Immunotherapy of ovarian cancer. II. In vitro generation and characterization of lymphokine-activated killer T cells from the peripheral blood of recurrent ovarian cancer patients by Lucci, 3rd, J A, Manetta, A, Cappuccini, F, Ininns, E K, Dett, C A, DiSaia, P, Yamamoto, R S, Berman, M L, Soopikian, J, Granger, G A

“…We examined the in vitro sensitivity of continuous ovarian cancer cells to lymphokine-activated killer T cells (T-LAK) alone or in combination with cytokines…”
Get more information

Effect of testosterone on human corpus luteum steroidogenesis in vitro by Rodriguez-Rigau, L J, Steinberger, E, Atkins, B J, Lucci, Jr, J A

Get more information

A phase II trial of pyrazoloacridine (PZA) in squamous carcinoma of the cervix: A Gynecologic Oncology Group Study by PLAXE, Steven C, BLESSING, John A, LUCCI, Joseph A, HURTEAU, Jean A

“…The Gynecologic Oncology Group performed a Phase II study to determine the response rate of Pyrazoloacridine (PZA) in patients with advanced, persistent or…”
Get full text

Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancer by Cappuccini, F, Yamamoto, R S, DiSaia, P J, Grosen, E A, Gatanaga, M, Lucci, J A, Ininns, E K, Gatanaga, T, Granger, G A

“…Ascites obtained from human ovarian cancer patients contains material(s) that inhibit the cytolytic activity of tumor necrosis factor (TNF) and lymphotoxin…”
Get more information